144 related articles for article (PubMed ID: 31911154)
1. Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model.
Schiapparelli P; Zhang P; Lara-Velazquez M; Guerrero-Cazares H; Lin R; Su H; Chakroun RW; Tusa M; Quiñones-Hinojosa A; Cui H
J Control Release; 2020 Mar; 319():311-321. PubMed ID: 31911154
[TBL] [Abstract][Full Text] [Related]
2. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme.
Checa-Chavarria E; Rivero-Buceta E; Sanchez Martos MA; Martinez Navarrete G; Soto-Sánchez C; Botella P; Fernández E
Mol Pharm; 2021 Apr; 18(4):1558-1572. PubMed ID: 33645231
[TBL] [Abstract][Full Text] [Related]
3. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering.
Chakroun RW; Wang F; Lin R; Wang Y; Su H; Pompa D; Cui H
ACS Nano; 2019 Jul; 13(7):7780-7790. PubMed ID: 31117370
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells.
Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; Quiñones-Hinojosa A; Cui H
Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma.
Lee BS; Amano T; Wang HQ; Pantoja JL; Yoon CW; Hanson CJ; Amatya R; Yen A; Black KL; Yu JS
ACS Nano; 2013 Apr; 7(4):3061-77. PubMed ID: 23557138
[TBL] [Abstract][Full Text] [Related]
6. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S
Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma.
Wang F; Huang Q; Su H; Sun M; Wang Z; Chen Z; Zheng M; Chakroun RW; Monroe MK; Chen D; Wang Z; Gorelick N; Serra R; Wang H; Guan Y; Suk JS; Tyler B; Brem H; Hanes J; Cui H
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2204621120. PubMed ID: 37098055
[TBL] [Abstract][Full Text] [Related]
8. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy.
Ma W; Su H; Cheetham AG; Zhang W; Wang Y; Kan Q; Cui H
J Control Release; 2017 Oct; 263():102-111. PubMed ID: 28082170
[TBL] [Abstract][Full Text] [Related]
10. Theranostic supramolecular polymers formed by the self-assembly of a metal-chelating prodrug.
Su H; Cui Y; Wang F; Zhang W; Zhang C; Wang R; Cui H
Biomater Sci; 2021 Jan; 9(2):463-470. PubMed ID: 32648884
[TBL] [Abstract][Full Text] [Related]
11. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
[TBL] [Abstract][Full Text] [Related]
12. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
[TBL] [Abstract][Full Text] [Related]
13. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
15. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
16. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
17. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
[TBL] [Abstract][Full Text] [Related]
18. Kinetically-stable small-molecule prodrug nanoassemblies for cancer chemotherapy.
Zheng Y; Ying X; Su Y; Jin X; Xu Q; Li Y
Int J Pharm; 2021 Mar; 597():120369. PubMed ID: 33577910
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations.
Sun S; Shi D; Liu J; Lu J; Dou P; Zhou Z; Chen Y
J Vis Exp; 2023 Feb; (192):. PubMed ID: 36912553
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of camptothecin: An esterase-activatable prodrug delivered by a self-emulsifying formulation that improves efficacy in colorectal cancer.
Fang T; Ye Z; Chen X; Wang Y; Wan J; Wang H
Int J Pharm; 2021 Apr; 599():120399. PubMed ID: 33647408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]